ClinicalTrials.gg
RecruitingNCT07035171Updated Jun 29, 2025

CABGpreHAB - a Feasibility Study Protocol

An interventional study of Multimodal prehabilitation intervention and Control (Standard treatment) in Ischaemic Heart Disease, Prehabilitation and Coronary Artery Bypass, sponsored by Rigshospitalet, Denmark. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-29.

Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Jun 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Coronary Artery Disease by Rigshospitalet, Denmark — 5 open to participants now, 6 under way, none of them phase 3. Coronary Artery Disease · Rigshospitalet, Denmark.

Planned enrollment
14th of 15
50 · median 331
Started
2025
the only one that year
No phase
14 of 18
5 open now
Registered
18th of 18
by date

Among the 18 studies in Coronary Artery Disease by Rigshospitalet, Denmark, this one is the 14th largest by planned enrollment of the 15 interventional ones that give a count, is the only one that started in 2025, is one of 14 with no phase, and was the 18th registered.

Coronary Artery Disease

4,866 studies on the registry are indexed under Coronary Artery Disease; 892 are open to participants now.

Browse Coronary Artery Disease studies →

Open to participants now

5 of the 18 studies in Coronary Artery Disease by Rigshospitalet, Denmark are open now, in 3 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Who these studies take

Of the 591 Coronary Artery Disease studies recruiting now, 404 (68%) set no upper age limit and 68 (12%) stop at 75 or younger; 37 take children under 18; 49 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Coronary Artery Disease by Rigshospitalet, Denmark, or all of them as a file.
02

Study summary

Patients with ischemic heart disease (IHD) awaiting coronary artery bypass graft (CABG) surgery often face challenges like advanced age, frailty, comorbidities, and physical inactivity. These factors, combined with the physiological and psychological stress of surgery, can hinder postoperative recovery. Traditionally, strategies to improve surgical outcomes focus on the intra- and postoperative periods. However, the pre-surgery waiting period offers a "window of opportunity" for prehabilitation, which aims to enhance patients' functional capacity through exercise, nutrition, and psychological support.

The CABGpreHAB feasibility study evaluates the feasibility of a home-based multimodal prehabilitation intervention for patients awaiting elective CABG surgery. This randomized pilot study compares the intervention plus usual care to usual care alone, assessing feasibility outcomes like recruitment, retention, attrition, fidelity, and adherence. The study aims to optimize a subsequent full-scale randomized controlled trial (RCT) and improve patient outcomes by leveraging the pre-surgery period for prehabilitation.

Read the detailed description

Advanced age, frailty, comorbidity, and physical inactivity are often present in patients with ischemic heart disease (IHD) awaiting coronary artery bypass graft surgery (CABG). These characteristics, as well as the physiological impact of having surgery, are significant homeostatic disturbances where patients postoperatively suffer from physical symptoms and a lack of return to independence. Cardiac surgery invariably induces varying degrees of physiological stress, impacting multiple organ systems, and imposes a psychological burden. As age increases, patient complexity and comorbid burden grow more common in patients undergoing cardiac surgery; innovative strategies are required to alleviate the risk of adverse outcomes. Strategies to improve outcomes from surgery and accelerate return to baseline levels have traditionally focused on the intra- and postoperative period, nevertheless, the waiting period before surgery might offer an opportunity for improving the safety and outcome of the surgical intervention and improving patients' motivation in postoperative rehabilitation and recovery time. Prehabilitation is a newly introduced term that reflects a proactive process of enhancing an individual's functional capacity between diagnosis and scheduled surgery, intending to improve the patient's capacity to withstand the upcoming physiologic stress of surgery and thus avoid complications. This period of awaiting surgery is proposed as a "window of opportunity" to address poor nutritional status, low physical fitness, and high emotional distress. The role of multimodal prehabilitation combining exercise training, nutritional optimization, and psychological support, in patients with IHD awaiting CABG surgery, is sparse and unknown in a Danish setting

Objective:

This CABG preHAB feasibility study is conducted to evaluate the feasibility of delivering a homebased multimodal prehabilitation intervention for patients awaiting elective CABG surgery with the purpose to optimize a subsequent full-scale RCT.

Design:

The CABGpreHAB feasibility study is designed as a randomized pilot study, aiming to assess the feasibility of a multimodal prehabilitation intervention plus usual care versus usual care alone in patients awaiting elective CABG surgery. It is an investigator-initiated study designed as an open-label, single-center randomized controlled feasibility study (allocation ratio 1:1) with blinded outcome assessment, designed to assess the method proposed for use in a larger RCT.

Study population:

Patients aged more than 18 years awaiting elective CABG-surgery

Primary outcomes:

Feasibility outcomes include:

Recruitment and retention rates. The recruitment rate will be determined by the number of individuals participating in the study out of those who are eligible/admissible but refuse to participate. First, the investigators will evaluate the number of patients that can be included in the study during the inclusion period. A proportion of 60% or more of patients awaiting elective CABG surgery who are eligible for the study is acceptable. Retention will be assessed by the percentage of participants who remain in the study from the beginning to the end of the study (30 days post-surgery).

Attrition rates. Attrition is defined by the number of individuals who consent to participate in the study but drop out before the end of the intervention period, regardless of group allocation.

Fidelity. Fidelity of delivery of the webcam-based exercise training intervention will be assessed qualitatively by 8-10 semi-structured interviews, the day before surgery, by a research nurse.

Adherence to the interventions will be measured by using the number of telephone counselling and tele-exercise sessions delivered out of the theoretical number that could have been delivered based on the surgical wait time of each participant. Adherence to the home-based tele-exercise training sessions and telephone counselling by assessing the number of sessions applied in the intervention group. This will be collected by the patient's recorded physical activity logbook, by weekly phone calls, and by accelerometer data. Adherence with the prehabilitation program will be assessed against the target of individuals achieving > 70% of the prescribed exercise program (self-reported) + during the study follow-up with phone calls. Inclusion in the CABGpreHAB study must be attractive to at least 30% of eligible patients who meet the inclusion criteria. The interventions must be widely accepted, with at least 70% of included participants completing 70% or more of the planned sessions in the intervention group. Safety of the intervention will be determined based on the number and nature of adverse events (AE).

Secondary outcomes:

Secondary outcomes will assess the patients' responses to the multimodal prehabilitation programme, and data will be collected on explorative outcomes, measured at baseline, the day before surgery and 30 days PO.

03

Conditions studied

  • Ischaemic Heart Disease
  • Prehabilitation
  • Coronary Artery Bypass
  • Feasibility Studies
  • Multimodal Intervention
  • Adult

Keywords

  • Prehabilitation, CABG surgery, adult, preoperative,homebased
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Planned to have elective isolated first-time CABG surgery.
  • 18 years or older
  • Two weeks or more before surgery
  • Speaks and understands Danish.
  • Gives written .

Exclusion criteria

Exclusion Criteria:

  • Patient with unstable angina pectoris and/ or MI during the last two weeks.
  • Left main stem stenosis >50%
  • \< 35%
  • Significant ventricular arrhythmia
  • Orthopedic or neurologic preconditions precluding exercise training.
  • Inability to attend the prehabilitation program due to physical limitations.
  • Patients who have cognitive deficits that would disqualify prehabilitation.
  • Severe heart failure, Class IV
  • Lack of capacity to consent
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

LVEF (left ventricular ejection fraction)

The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    CABGpreHAB multimodal prehabilitation intervention + usual care

    Patients randomized to the multimodal prehabilitation programme will, besides usual care, receive home-based preoperative interventions that consist of: Web-based exercise intervention supervised by skilled physiotherapists and delivered via a tablet. Each session lasts 60 minutes, three times per week for the prehabilitation period. Patients will be instructed to perform daily exercise tasks such as brisk walking and sit-to-stand exercises. Phone call and consultation delivered by a specialised nurse once a week. This consultation will deliver psychosocial support, equipping patients with coping strategies to mitigate stress, anxiety, and depression. Furthermore, nutritional advice will take place at these consultations, as well as advice on smoking cessation and alcohol cessation.

    Other: Multimodal prehabilitation intervention

  • Other
    Control group

    Participants assigned to the control group will receive usual care.

    Other: Control (Standard treatment)

Interventions

  • OtherMultimodal prehabilitation intervention

    Multimodal prehabilitation interventions (CABGpreHAB): * Home-based exercise intervention delivered by a skilled physiotherapist via a web-based application. * Nutritional intervention * Psycho-educative intervention * Smoking cessation * Alcohol cessation

  • OtherControl (Standard treatment)

    This includes standard information about CABG surgery, pre- and postoperative care, and postoperative physical activity advice. Patients are either admitted days before or on the day before surgery. They receive written materials and links to animated videos about preparing for surgery. This preparation includes counseling with a multidisciplinary team, including a department nurse, a physiotherapist, a cardiac anesthesiologist, and a surgeon.

06

What researchers measure

Primary outcomes

  1. Feasibility outcome: recruitement rate

    Determined by the number of individuals participating in the study out of those eligible during the inclusion period.

    Time frame: Through study completition, an average of 1 year

  2. Feasibility outcome: Attrition rates

    Defined by the numbers of individuals who give consent to participate, but drop out before study ends.

    Time frame: Up to 30 days post surgery index

  3. Feasibility outcome: Fidelity

    Fidelity of delivery on the web-based exercise training intervention will be assessed qualitatively by semi-structured interviews

    Time frame: preoperative

  4. Feasibility outcome: Adherence rates

    Adherence will be assessed by measuring the number of telephone counseling and exercise sessions delivered during the intervention period.

    Time frame: Preoperative

  5. Feasibility outcome: Safety

    Safety of the intervention will be determined based on the number and nature of adverse events.

    Time frame: From enrolement to the day before surgery

Secondary outcomes

  1. Exercise capacity

    6MWT measures total walking distance in meters completed in six minutes

    Time frame: Three times: at baseline, preoperative and 30 days post surgery index

  2. Muscle strength

    30 seconds sit-to-stand measured by numbers of sit-to-stands in 30 seconds

    Time frame: Three times: at baseline, preoperative and 30 days post surgery index

  3. Muscle strength handgrip

    Measured in kilograms using a hand-held dynamometer

    Time frame: At baseline and preoperative

  4. Bodycomposition

    Using a Bioelectrical Impedance Analyzer (BIA), body composition estimation: fat mass in kilograms, Fat mass as a percentage of weight, Fat-free mass in kilograms, Fat-free mass as a percentage of weight

    Time frame: At baseline and preoperative

  5. Nutritional status

    Weight and height combined to report BMI in kg/m\^2, and Screened by the NRS2002 score

    Time frame: At baseline and preoperative

  6. Daily physical activity

    SENS motion accelerometer measures minutes of physical activity as steps, Cyckling running Standing Laying

    Time frame: Three times: at baseline, preoperative and 30 days post surgery index

  7. HRQOL

    The Questionnaire SF-12 measures overall health status

    Time frame: Three times: at baseline, preoperative and 30 days post surgery index

  8. Heart-specific QoL

    The Questionnaire HeartQoL measures health-related quality of life in patients with ischemic heart disease

    Time frame: Three times: at baseline, preoperative and 30 days post surgery index

  9. Anxiety

    The State-Trait Anxiety Inventory Questionnaire measures two disitnc types of anxiety

    Time frame: Three times: at baseline, preoperative and 30 days post surgery index

  10. Depression

    The PHQ-4 Questionnaire measures depression and anxiety

    Time frame: Three times: at baseline, preoperative and 30 days post surgery index

  11. Sense of coherence

    The SOC-13 Questionnaire assesses an individual´s ability to manage stress and maintain health

    Time frame: At baseline

  12. Self-efficacy/self-management

    The PAM13 Questionnaire assesses an individual's knowledge, skill, and confidence for self-management

    Time frame: Three times: at baseline, preoperative and 30 days post surgery index

  13. Tobacco uses status

    Self-Reported Questionnaire

    Time frame: Three times: at baseline, preoperative and 30 days post surgery index

  14. Alcohol uses status

    Self-Reported Questionnaire

    Time frame: Three times: at baseline, preoperative and 30 days post surgery index

Other outcomes

  1. Complications postoperatively

    Rates of pneumonia, atelectasis, hemorrhage, cardiac arrhythmias, and delirium will be measured postoperatively

    Time frame: From date of surgery and up to 30 days postopetively.

  2. ICU-LOS

    ICU-LOS will be calculated in hours

    Time frame: From date and time of surgery until the date and time of discharge to the ward.

  3. LOS

    LOS will be calculated in days

    Time frame: From date of surgery until date of discharge from the ward

  4. DAOH30

    DAOH30 will be calculated in days

    Time frame: From date of surgery and up to 30 days postopetively.

  5. Participating in Cardiac rehabilitation

    Participation will be calculated in percentage

    Time frame: At 30 days postoperatively

  6. Bloodtest

    HGB measured in mmol/l Albumin measured in g/l CRP measured in mg/l Creatinine measured in micromol/l

    Time frame: At baseline and postoperatively day 4

07

Study locations

1 of 1 sites recruiting
  • The Department of Heart and Lung Surgery, Copenhagen University hospital Rigshospitalet
    Copenhagen, 2100, Denmark
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Jun 2026, 11 months after the start.

Of 756 non-industry interventional studies with no phase under Coronary Artery Disease, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's planned 11 months is below that.

Counting every sponsor, half of 933 studies reached it within 30 months; a quarter within 15 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
May 19, 2025
First posted
Jun 24, 2025
StartActual
Jun 24, 2025
Primary completionEst.
Jun 18, 2026
CompletionEst.
Jul 18, 2026
Last update
Jun 29, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07035171
Responsible party
Dorte Bæk Olsen (Clinical Nurse Specialist, Rigshospitalet, Denmark) — Principal investigator
First posted
Jun 24, 2025
Start date
Jun 24, 2025
Primary completion
Jun 18, 2026 (estimated)
Completion
Jul 18, 2026 (estimated)
Last update
Jun 29, 2025

Study contacts

Dorte Baek Olsen, PhD student
Contact
dorte.baek.olsen@regionh.dk
+4526625705
Ida E Hoejskov, PhD
principal investigator · Department of Heart Disease, Rigshospitalet, Copenhagen University Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion